Sanofi and GSK ask for approval of vaccine against severe COVID-19

Édité par Ed Newman
2022-02-24 22:32:05

Pinterest
Telegram
Linkedin
WhatsApp

The drugmakers Sanofi and GSK have announced they will request emergency use authorization for their COVID-19 vaccine from European and U.S. regulators.

Geneva, February 25 (RHC)-- The drugmakers Sanofi and GSK have announced they will request emergency use authorization for their COVID-19 vaccine from European and U.S. regulators. 

The companies say the Sanofi-GSK vaccine showed 100% efficacy at preventing severe disease and hospitalization in a late-state clinical trial and 58% efficacy against symptomatic disease. 

Sanofi and GSK received billions of dollars from Operation Warp Speed, the Trump administration’s initiative to fast-track vaccine development. 

 



Commentaires


Laissez un commentaire
Tous les champs sont requis
Votre commentaire ne sera pas publié
captcha challenge
up